255 related articles for article (PubMed ID: 31748274)
1. Anti-CD20 therapy depletes activated myelin-specific CD8
Sabatino JJ; Wilson MR; Calabresi PA; Hauser SL; Schneck JP; Zamvil SS
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25800-25807. PubMed ID: 31748274
[TBL] [Abstract][Full Text] [Related]
2. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
3. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
4. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.
Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
Int Immunol; 2003 Sep; 15(9):1073-80. PubMed ID: 12917259
[TBL] [Abstract][Full Text] [Related]
5. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida T; Parker KC; Turner RV; McFarland HF; Coligan JE; Biddison WE
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10859-63. PubMed ID: 7526383
[TBL] [Abstract][Full Text] [Related]
6. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ
J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096
[TBL] [Abstract][Full Text] [Related]
7. White matter lesions in multiple sclerosis are enriched for CD20
Hsiao CC; Fransen NL; van den Bosch AMR; Brandwijk KIM; Huitinga I; Hamann J; Smolders J
Eur J Immunol; 2021 Feb; 51(2):483-486. PubMed ID: 32949467
[TBL] [Abstract][Full Text] [Related]
8. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis.
Bielekova B; Sung MH; Kadom N; Simon R; McFarland H; Martin R
J Immunol; 2004 Mar; 172(6):3893-904. PubMed ID: 15004197
[TBL] [Abstract][Full Text] [Related]
9. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
Jilek S; Schluep M; Harari A; Canales M; Lysandropoulos A; Zekeridou A; Pantaleo G; Du Pasquier RA
J Immunol; 2012 May; 188(9):4671-80. PubMed ID: 22461701
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
[TBL] [Abstract][Full Text] [Related]
12. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
14. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice.
Mars LT; Bauer J; Gross DA; Bucciarelli F; Firat H; Hudrisier D; Lemonnier F; Kosmatopoulos K; Liblau RS
J Immunol; 2007 Oct; 179(8):5090-8. PubMed ID: 17911594
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
16. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
[TBL] [Abstract][Full Text] [Related]
17. Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.
Palanichamy A; Jahn S; Nickles D; Derstine M; Abounasr A; Hauser SL; Baranzini SE; Leppert D; von Büdingen HC
J Immunol; 2014 Jul; 193(2):580-586. PubMed ID: 24928997
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes.
Hong J; Zang YCQ; Li S; Rivera VM; Zhang JZ
Eur J Immunol; 2004 Mar; 34(3):870-881. PubMed ID: 14991617
[TBL] [Abstract][Full Text] [Related]
19. HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
Pannemans K; Broux B; Goris A; Dubois B; Broekmans T; Van Wijmeersch B; Geraghty D; Stinissen P; Hellings N
Mult Scler; 2014 Jun; 20(7):790-801. PubMed ID: 24144875
[TBL] [Abstract][Full Text] [Related]
20. Association of New Putative Epitopes of Myelin Proteolipid Protein (58-74) with Pathogenesis of Multiple Sclerosis.
Zamanzadeh Z; Ahangari G; Ataei M; Pouragahi S; Nabavi SM; Sadeghi M; Sanati MH
Iran J Allergy Asthma Immunol; 2016 Oct; 15(5):394-402. PubMed ID: 27917626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
